| Nov 11 |
Moderna’s mRESVIA vaccine gains Health Canada approval
|
| Nov 9 |
Earnings Beat: Moderna, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
|
| Nov 9 |
What Moved Markets This Week
|
| Nov 8 |
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn
|
| Nov 8 |
2 Biotech Stocks You Can Buy Hand Over Fist This Month
|
| Nov 8 |
Moderna (MRNA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
|
| Nov 8 |
Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
|
| Nov 8 |
Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
|
| Nov 8 |
Moderna Third Quarter 2024 Earnings: Beats Expectations
|
| Nov 8 |
Moderna Inc (MRNA) Q3 2024 Earnings Call Highlights: Strong Revenue and Strategic Growth Amidst ...
|
